Alector Stock Forecast, Price & News

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alector in the last twelve months. There are currently 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Alector stock.
View analyst ratings for Alector or view top-rated stocks.

Wall Street analysts have given Alector a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Alector wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Alector saw a drop in short interest during the month of July. As of July 15th, there was short interest totaling 6,180,000 shares, a drop of 16.5% from the June 30th total of 7,400,000 shares. Based on an average daily volume of 1,400,000 shares, the short-interest ratio is presently 4.4 days. Currently, 11.0% of the shares of the stock are short sold.
View Alector's Short Interest.

Alector is scheduled to release its next quarterly earnings announcement on Tuesday, August 10th 2021.
View our earnings forecast for Alector.

Alector, Inc. (NASDAQ:ALEC) issued its earnings results on Tuesday, May, 4th. The company reported ($0.66) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.69) by $0.03. The firm earned $4.11 million during the quarter, compared to analysts' expectations of $6.42 million. Alector had a negative trailing twelve-month return on equity of 69.73% and a negative net margin of 1,122.03%.
View Alector's earnings history.

Alector's stock was trading at $24.92 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ALEC stock has increased by 20.1% and is now trading at $29.94.
View which stocks have been most impacted by COVID-19.

6 analysts have issued 1 year price targets for Alector's stock. Their forecasts range from $29.00 to $57.00. On average, they anticipate Alector's stock price to reach $38.29 in the next year. This suggests a possible upside of 27.9% from the stock's current price.
View analysts' price targets for Alector or view top-rated stocks among Wall Street analysts.

4 employees have rated Alector CEO Arnon Rosenthal on Glassdoor.com. Arnon Rosenthal has an approval rating of 100% among Alector's employees. This puts Arnon Rosenthal in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Alector include CRISPR Therapeutics (CRSP), Neurocrine Biosciences (NBIX), Fate Therapeutics (FATE), Acceleron Pharma (XLRN), Denali Therapeutics (DNLI), Halozyme Therapeutics (HALO), Twist Bioscience (TWST), Beam Therapeutics (BEAM), Exelixis (EXEL), Recursion Pharmaceuticals (RXRX), Adaptive Biotechnologies (ADPT), Vir Biotechnology (VIR), Kodiak Sciences (KOD), SpringWorks Therapeutics (SWTX) and Abcam (ABCM).
View all of ALEC's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Alector investors own include Editas Medicine (EDIT), NVIDIA (NVDA), Pfizer (PFE), Advanced Micro Devices (AMD), Gossamer Bio (GOSS), Kaleido Biosciences (KLDO), QUALCOMM (QCOM), Intel (INTC), Micron Technology (MU) and Cisco Systems (CSCO).

(ALEC) raised $177 million in an initial public offering (IPO) on Thursday, February 7th 2019. The company issued 9,300,000 shares at $18.00-$20.00 per share. Morgan Stanley, BofA Merrill Lynch, Cowen and Barclays acted as the underwriters for the IPO.

Alector trades on the NASDAQ under the ticker symbol "ALEC."

Shares of ALEC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALEC stock can currently be purchased for approximately $29.94.

Alector has a market capitalization of $2.39 billion and generates $21.10 million in revenue each year. The company earns $-190,230,000.00 in net income (profit) each year or ($2.45) on an earnings per share basis.

Alector employs 181 workers across the globe.

The official website for Alector is www.alector.com.

Alector is headquartered at 131 OYSTER POINT BLVD. SUITE 600, SOUTH SAN FRANCISCO CA, 94080.

Alector's mailing address is 131 OYSTER POINT BLVD. SUITE 600, SOUTH SAN FRANCISCO CA, 94080. The company can be reached via phone at 415-231-5660 or via email at [email protected]